INSP vs UFPT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
INSP · Inspire Medical Systems$63.98 ▼ 3.83%
UFPT · UFP Technologies$303.47 ▲ 1.22%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- INSP -25.7%
- UFPT +29.4%
Head to head
| Metric | INSP | UFPT |
|---|---|---|
| Price | $63.98 | $303.47 |
| Change today | ▼ 3.83% | ▲ 1.22% |
| Market cap | $1.85B | $2.35B |
| Return, 3 months | +7.1% | -6.6% |
| Return, year to date | -30.6% | +36.7% |
| Return, 1 year | -21.8% | +34.2% |
| P/E (TTM) | 19.1 | 31.0 |
| P/B | 2.2 | 4.8 |
| P/E percentile vs own 5y | 67th | 52nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -7.6% | +15.1% |
| Net profit growth (YoY) | +108.7% | +21.4% |
| Gross margin | 86.1% | 28.5% |
| Operating margin | 6.0% | 15.2% |
| Net margin | 15.0% | 11.4% |
| Return on equity | 18.0% | 17.1% |
| Analyst target vs. price | +7.5% | – |
| Analyst buy share | 29% | – |
| RSI (14) | 40 | 54 |
| 30-day volatility | 50.7% | 61.7% |
| Max drawdown, 1 year | -72.2% | -30.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Hold | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- UFPT is the largest of the group by market value.
- UFPT has returned the most over the past year.
- INSP carries the lowest trailing P/E.
- UFPT is growing revenue fastest.
- INSP keeps the most profit per dollar of sales.
- INSP has been the calmest stock over the last 30 days.